Literature DB >> 27091440

In 2035, will all bacteria be multidrug resistant? We are not sure.

Kevin B Laupland1, Etienne Ruppé2, Stephan Harbarth3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27091440     DOI： 10.1007/s00134-016-4343-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Development of new antibiotics: taking off finally?

Authors:  Esther Bettiol; Stephan Harbarth
Journal:  Swiss Med Wkly       Date:  2015-07-31       Impact factor: 2.193

Review 2.  Alternatives to antibiotics-a pipeline portfolio review.

Authors:  Lloyd Czaplewski; Richard Bax; Martha Clokie; Mike Dawson; Heather Fairhead; Vincent A Fischetti; Simon Foster; Brendan F Gilmore; Robert E W Hancock; David Harper; Ian R Henderson; Kai Hilpert; Brian V Jones; Aras Kadioglu; David Knowles; Sigríður Ólafsdóttir; David Payne; Steve Projan; Sunil Shaunak; Jared Silverman; Christopher M Thomas; Trevor J Trust; Peter Warn; John H Rex
Journal:  Lancet Infect Dis       Date:  2016-01-13       Impact factor: 25.071

3.  Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections.

Authors:  Tommaso Cai; Gabriella Nesi; Sandra Mazzoli; Francesca Meacci; Paolo Lanzafame; Patrizio Caciagli; Liliana Mereu; Saverio Tateo; Gianni Malossini; Cesare Selli; Riccardo Bartoletti
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

4.  Society's failure to protect a precious resource: antibiotics.

Authors:  Jean Carlet; Peter Collignon; Don Goldmann; Herman Goossens; Inge C Gyssens; Stephan Harbarth; Vincent Jarlier; Stuart B Levy; Babacar N'Doye; Didier Pittet; Rosana Richtmann; Wing H Seto; Jos W M van der Meer; Andreas Voss
Journal:  Lancet       Date:  2011-04-07       Impact factor: 79.321

5.  A national cross-sectional study on socio-behavioural factors that influence physicians' decisions to begin antimicrobial therapy.

Authors:  E Velasco; W Espelage; M Faber; I Noll; A Ziegelmann; G Krause; T Eckmanns
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

Review 6.  Novel approaches are needed to develop tomorrow's antibacterial therapies.

Authors:  Brad Spellberg; John Bartlett; Rich Wunderink; David N Gilbert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-15       Impact factor: 21.405

7.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

Review 8.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 9.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 10.  The importance of source control in the management of severe skin and soft tissue infections.

Authors:  Christian Eckmann
Journal:  Curr Opin Infect Dis       Date:  2016-04       Impact factor: 4.915
View more
  3 in total

1.  Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study.

Authors:  Tiago Cravo Oliveira Hashiguchi; Driss Ait Ouakrim; Michael Padget; Alessandro Cassini; Michele Cecchini
Journal:  Euro Surveill       Date:  2019-05

2.  Changes in public knowledge and perceptions about antibiotic use and resistance in Jordan: a cross-sectional eight-year comparative study.

Authors:  Suzanne Abdelmalek; Rowan AlEjielat; Walid Abu Rayyan; Nidal Qinna; Dana Darwish
Journal:  BMC Public Health       Date:  2021-04-19       Impact factor: 3.295

3.  Microfluidic platform for spatially segregated experimental evolution studies with E. coli.

Authors:  Seokju Seo; Ramya Ganiga Prabhakar; Saoirse Disney-McKeethen; Xinhao Song; Yousif Shamoo
Journal:  STAR Protoc       Date:  2022-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.